|
|
|
|
|
|
|
Choosing The Ideal CDMO Partner For Cell Line Development
|
|
|
Partnering with a CDMO with a strong Cell Line Development (CLD) foundation is essential for biopharma companies looking to transition a protein from development to commercialization efficiently. Explore key factors in selecting the right CDMO partner for CLD, including expertise in host cell background, preparation for complex protein production, and an emphasis on optimizing and de-risking manufacturing.
|
|
|
|
|
|
|
This webinar explores innovative platform technologies that boost bioprocessing efficiency, focusing on advanced cell line development and analytical capabilities. Learn how these solutions accelerate the production of complex biotherapeutics and discover a new digital platform enhancing data transparency and CDMO-client communication.
|
|
|
|
|
|
A Flexible, Standardized CLD Platform For Biologics
|
As biotherapeutics become more complex, SUREtechnology Platform™, powered by Selexis®, streamlines cell line development by overcoming common expression bottlenecks. This advanced platform enables premium, stable, high-yield CHO-based cell line development with robust verification, genomic characterization, and monoclonality assessment.
|
|
• Request Information
|
|
|
|
|
|
|
|
|
|
|
Development Success Is A SURE Thing With SUREmAb
|
Leverage robust development strategies to optimize mAb development and manufacturing. Achieve efficiency, speed, and exceptional quality, while maximizing high titers and accelerated timelines to tox material with cost-effective workflows for the best return on investment.
|
|
• Request Information
|
|
|
|
|
|
|
|
|
DEVELOPMENT AND MANUFACTURING SERVICES FOR NEW BIOLOGICS
|
|
|
|
|
|
Turn Complexity Into Possibility With A Trusted CDMO Partner
|
Move past challenges to unlock new possibilities. Partner with an expert CDMO that brings innovative approaches, guidance, and advanced analytics to each stage of your project — from cell line development to manufacturing. Navigate development and manufacturing with confidence.
|
|
|
